Abstract
The placenta transfers nutrients, gases, and waste products between maternal and fetal circulations. Placental transfer capacity is determined by a wide range of factors such as placental surface area and thickness, the abundance of transporters, the gradient of concentrations between both maternal and fetal compartments, placental metabolism and utero-placental flows, and other environmental stimuli. Substances need to cross several cellular layers, among them the trophoblast, through different transport mechanisms such as simple or facilitated diffusion or active transport. Early placentation, which is very critical for optimum placental capacity, depends on the extensive remodeling of the maternal uterine vasculature producing low-resistance blood vessels that facilitate the exchange of nutrients and wastes between the mother and the fetus (Zhong et al. 2010). Proper placental development is critical for fetal growth and development (Myatt 2002). The shallow invasion of the spiral arterioles and the maternal decidual stroma by the extravillous trophoblasts (EVTs) results in poor maternal blood flow to the feto-placental unit. Consequently, this reduces oxygen and nutrients’ delivery to the fetus. Concomitantly, ischemia–reperfusion injury may follow inappropriate vasoconstriction of untransformed arteries, increasing oxidative stress, syncytiotrophoblast shedding, and maternal systemic vascular inflammation. All these are important features of preeclampsia (PE). In addition, the compromised placental growth and development may affect fetal growth and development due to the result of insufficient placental transfer of maternal nutrients such as lipids, glucose, amino acids, minerals, and vitamins. There are several other factors that affect the placental transport function such as interrelationships of maternal food intake, availability of nutrients in the maternal circulation, and ability of the placenta to efficiently transport substrates to the fetal circulation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aljada, A., O’Connor, L., Fu, Y. Y., & Mousa, S. A. (2008). PPAR gamma ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis. Angiogenesis, 11, 361–367.
Alwasel, S. H., Abotalib, Z., Aljarallah, J. S., Osmond, C., Al Omar, S. Y., Harrath, A., Thornburg, K., & Barker, D. J. (2012). The breadth of the placental surface but not the length is associated with body size at birth. Placenta, 33, 619–622.
Barker, D. J., Larsen, G., Osmond, C., Thornburg, K. L., Kajantie, E., & Eriksson, J. G. (2012). The placental origins of sudden cardiac death. International Journal of Epidemiology, 41, 1394–1399.
Barker, D. J., Osmond, C., Forsen, T. J., Thornburg, K. L., Kajantie, E., & Eriksson, J. G. (2013a). Foetal and childhood growth and asthma in adult life. Acta Paediatrica, 102, 732–738.
Barker, D., Osmond, C., Grant, S., Thornburg, K. L., Cooper, C., Ring, S., & Davey-Smith, G. (2013b). Maternal cotyledons at birth predict blood pressure in childhood. Placenta, 34, 672–675.
Barker, D. J., Osmond, C., Thornburg, K. L., Kajantie, E., & Eriksson, J. G. (2011). The lifespan of men and the shape of their placental surface at birth. Placenta, 32, 783–787.
Barker, D. J., Osmond, C., Thornburg, K. L., Kajantie, E., & Eriksson, J. G. (2013c). The shape of the placental surface at birth and colorectal cancer in later life. American Journal of Human Biology, 25, 566–568.
Barker, D. J., Thornburg, K. L., Osmond, C., Kajantie, E., & Eriksson, J. G. (2010). The surface area of the placenta and hypertension in the offspring in later life. International Journal of Developmental Biology, 54, 525–530.
Basak, S., Das, M. K., & Duttaroy, A. K. (2013). Fatty acid-induced angiogenesis in first trimester placental trophoblast cells: possible roles of cellular fatty acid-binding proteins. Life Sciences, 93, 755–762.
Basak, S., & Duttaroy, A. K. (2012). Leptin induces tube formation in first-trimester extravillous trophoblast cells. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 164, 24–29.
Basak, S., & Duttaroy, A. K. (2013a). cis-9, trans-11 conjugated linoleic acid stimulates expression of angiopoietin like-4 in the placental extravillous trophoblast cells. Biochimica et Biophysica Acta, 1831, 834–843.
Basak, S., & Duttaroy, A. K. (2013b). Effects of fatty acids on angiogenic activity in the placental extravillious trophoblast cells. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 88, 155–162.
Burton, G. J., Charnock-Jones, D. S., & Jauniaux, E. (2009). Regulation of vascular growth and function in the human placenta. Reproduction, 138, 895–902.
Demir, R., Kayisli, U. A., Seval, Y., Celik-Ozenci, C., Korgun, E. T., Demir-Weusten, A. Y., & Huppertz, B. (2004). Sequential expression of VEGF and its receptors in human placental villi during very early pregnancy: Differences between placental vasculogenesis and angiogenesis. Placenta, 25, 560–572.
Demir, A. S., & Talpur, F. N. (2010). Chemoenzymatic conversion of linoleic acid into conjugated linoleic acid. Journal of Agricultural and Food Chemistry, 58, 1646–1652.
Elmasri, H., Karaaslan, C., Teper, Y., Ghelfi, E., Weng, M., Ince, T. A., Kozakewich, H., Bischoff, J., & Cataltepe, S. (2009). Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells. The FASEB Journal, 23, 3865–3873.
Eriksson, J., Forsen, T., Tuomilehto, J., Osmond, C., & Barker, D. (2000). Fetal and childhood growth and hypertension in adult life. Hypertension, 36, 790–794.
Eriksson, J. G., Kajantie, E., Thornburg, K. L., Osmond, C., & Barker, D. J. (2011). Mother’s body size and placental size predict coronary heart disease in men. European Heart Journal, 32, 2297–2303.
Gardosi, J., Chang, A., Kalyan, B., Sahota, D., & Symonds, E. M. (1992). Customised antenatal growth charts. Lancet, 339, 283–287.
Harding, J. E. (2001). The nutritional basis of the fetal origins of adult disease. International Journal of Epidemiology, 30, 15–23.
Johnsen, G. M., Basak, S., Weedon-Fekjaer, M. S., Staff, A. C., & Duttaroy, A. K. (2011). Docosahexaenoic acid stimulates tube formation in first trimester trophoblast cells, HTR8/SVneo. Placenta, 32, 626–632.
Kajantie, E., Thornburg, K. L., Eriksson, J. G., Osmond, C., & Barker, D. J. (2010). In preeclampsia, the placenta grows slowly along its minor axis. International Journal of Developmental Biology, 54, 469–473.
Kang, J. H., Song, H., Yoon, J. A., Park, D. Y., Kim, S. H., Lee, K. J., Farina, A., Cho, Y. K., Kim, Y. N., Park, S. W., Kim, G. J., Shim, S. H., & Cha, D. H. (2011). Preeclampsia leads to dysregulation of various signaling pathways in placenta. Journal of Hypertension, 29, 928–936.
Mainigi, M. A., Olalere, D., Burd, I., Sapienza, C., Bartolomei, M., & Coutifaris, C. (2014). Peri-implantation hormonal milieu: Elucidating mechanisms of abnormal placentation and fetal growth. Biology of Reproduction, 90, 26.
Makris, A., Thornton, C., Thompson, J., Thomson, S., Martin, R., Ogle, R., Waugh, R., Mckenzie, P., Kirwan, P., & Hennessy, A. (2007). Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. Kidney International, 71, 977–984.
Massaro, M., Scoditti, E., Carluccio, M. A., Campana, M. C., & DE Caterina, R. (2010). Omega-3 fatty acids, inflammation and angiogenesis: Basic mechanisms behind the cardioprotective effects of fish and fish oils. Cellular and Molecular Biology, 56, 59–82.
Maynard, S. E., Moore Simas, T. A., Bur, L., Crawford, S. L., Solitro, M. J., & Meyer, B. A. (2010). Soluble endoglin for the prediction of preeclampsia in a high risk cohort. Hypertension in Pregnancy, 29, 330–341.
Moon, E. J., Lee, Y. M., & Kim, K. W. (2003). Anti-angiogenic activity of conjugated linoleic acid on basic fibroblast growth factor-induced angiogenesis. Oncology Reports, 10, 617–621.
Murota, S., Kanayasu, T., Nakano-Hayashi, J., & Morita, I. (1991). Involvement of eicosanoids in angiogenesis. Advances in Prostaglandin, Thromboxane, and Leukotriene Research, 21B, 623–626.
Myatt, L. (2002). Role of placenta in preeclampsia. Endocrine, 19, 103–111.
Pavlov, N., Hatzi, E., Bassaglia, Y., Frendo, J. L., Evain Brion, D., & Badet, J. (2003). Angiogenin distribution in human term placenta, and expression by cultured trophoblastic cells. Angiogenesis, 6, 317–330.
Roseboom, T. J., Painter, R. C., de Rooij, S. R., van Abeelen, A. F., Veenendaal, M. V., Osmond, C., & Barker, D. J. (2011). Effects of famine on placental size and efficiency. Placenta, 32, 395–399.
Rugg-Gunn, P. J. (2012). Epigenetic features of the mouse trophoblast. Reproductive Biomedicine Online, 25, 21–30.
Spencer, L., Mann, C., Metcalfe, M., Webb, M., Pollard, C., Spencer, D., Berry, D., Steward, W., & Dennison, A. (2009). The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential. European Journal of Cancer, 45, 2077–2086.
Taki, A., Abe, M., Komaki, M., Oku, K., Iseki, S., Mizutani, S., & Morita, I. (2012). Expression of angiogenesis-related factors and inflammatory cytokines in placenta and umbilical vessels in pregnancies with preeclampsia and chorioamnionitis/funisitis. Congenital Anomalies (Kyoto), 52, 97–103.
Tobin, K. A., Harsem, N. K., Dalen, K. T., Staff, A. C., Nebb, H. I., & Duttaroy, A. K. (2006). Regulation of ADRP expression by long-chain polyunsaturated fatty acids in BeWo cells, a human placental choriocarcinoma cell line. Journal of Lipid Research, 47, 815–823.
Torry, D. S., Wang, H. S., Wang, T. H., Caudle, M. R., & Torry, R. J. (1998). Preeclampsia is associated with reduced serum levels of placenta growth factor. American Journal of Obstetrics and Gynecology, 179, 1539–1544.
Wang, W., Feng, L., Zhang, H., Hachy, S., Satohisa, S., Laurent, L. C., Parast, M., Zheng, J., & Chen, D. B. (2012). Preeclampsia up-regulates angiogenesis-associated microRNA (i.e., miR-17, -20a, and -20b) that target ephrin-B2 and EPHB4 in human placenta. Journal of Clinical Endocrinology and Metabolism, 97, E1051–E1059.
Zhang, Y., & Daaka, Y. (2011). PGE2 promotes angiogenesis through EP4 and PKA Cgamma pathway. Blood, 118, 5355–5364.
Zhong, Y., Tuuli, M., & Odibo, A. O. (2010). First-trimester assessment of placenta function and the prediction of preeclampsia and intrauterine growth restriction. Prenatal Diagnosis, 30, 293–308.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Duttaroy, A.K., Basak, S. (2016). Placentation as a Predictor of Feto-Placental Outcome: Effects of Early Nutrition. In: Early Nutrition and Lifestyle Factors. Springer, Cham. https://doi.org/10.1007/978-3-319-38804-5_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-38804-5_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-38802-1
Online ISBN: 978-3-319-38804-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)